Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BIG SHOUT OUT AND TY TO ATS
Guys and Gals thanks man , especially AT , Big money Upward and Chris216
I have this old ass account with TD that I rarely check. Had a few no bid DOG's in there ( Lotto's ) I bought @ .0001. I dont do ihub a lot or have my scanner's set up for these low POS. Stopped by da board today saw you commenting on these.I had to dig through my books for sign in and password lol. Sold one for a trip and one for a foresome. Small change but gone forever from my account !!!!! SMVI TCHH Hasta La Vista Going to have to visit more , been reading back looks like you guys have been tearing it up on the low Nazzys and Trips as well as everything in between. Whooooaaaaaa! Be well.
Yeh I love it here. Try to visit every couple of years. You're right bars are wild , good times
Awwww Thanks Nitty that's a nice compliment
Dont know where you live in Florida ( or wherever ) but if you head to the extreme South East we can hang. Im on S Roosevelt in Key West. We can hang have a few drinks and Ill tell you if I think you"re a true Nitwit and you can size me up and tell me if you think I'm a retired stock promoter. Lolzzzzzzzzzzzzzz
Hey ATS Ill try not to do any more PWI's. ( posting while intoxicated)after tonight .... that post was borderline nonsense and understandable. nhahaha crazy night. Im back stateside and couldnt help but to have a few drinks during " State Of Da Union " Watched the whole thing in the man cave. 2 large TV's 1 regular TV mostly CNBC all the time tonight chose ABC, and a computer hooked up to other monitor with live realtime second by second futures.If you call yourself a trader and a force to be reckoned with, than you have to watch how every word of the President of US's speech effects the market, how the world reacted to his speech minute by minute,our dollars vs others, oil, precious metals etc etc. Its an amazing site to see to the accredited investor and money man. numbers rolling, and rolling up and down ,trying to decide truth from lies, amazing sight. The other side of the pond opening soon, we will see what they think . All and all nobody will have any idea on market response until early AM. Fucked up game we play.Response to AT , my bro , Im working on it.....Good Luck ALL
That all depend's. I'm just getting home and Im 8 hours ahead of US , soooooooooooo I think weekend's rule!!!!!!!!! Amazing evening!!! Now you Ang seem like a (+%) winner so I can see you looking forward to Monday. Losers on the other hand might thing differently. Be well ATS just passsing through before I collapse. lol . Have a great week.
Provectus's PV-10 Path to Initial Approval in U.S. Now Clear Per FDA Meeting Minutes
Provectus Biopharmaceuticals, Inc. (PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, today announced that it has received the official minutes from the Type C meeting held with the FDA’s Division of Oncology Products 2 on December 16, 2013. The purpose of the meeting was to determine which of the available paths that Provectus's novel investigational oncology drug PV-10 will take in pursuit of initial FDA approval and commercialization. PV-10, a 10% solution of rose bengal disodium, is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, while inducing a secondary tumor-specific immune response. As a result of this meeting, Provectus will submit data from its Phase 2 study in a formal breakthrough therapy designation (BTD) request this quarter, and should receive a decision within 60 days of receipt of that request.
With the passage of the Food and Drug Administration Safety and Innovation Act (FDASIA) in July 2012, the Food and Drug Administration (FDA) was given powerful expedited tools to speed patient access to innovative medicines for serious or life-threatening conditions (Food and Drug Administration Safety and Innovation Act (FDASIA)). FDASIA initiatives such as breakthrough therapy designation are designed to accelerate approval for new drugs that show preliminary clinical evidence of a large treatment effect. A key feature of BTD authorizes the Agency to take steps to ensure that the design of the clinical trials are as efficient as practicable, when scientifically appropriate, such as by minimizing the number of patients exposed to a potentially less efficacious treatment. Requests for BTD are reviewed and granted or rejected within 60 days of receipt. As Provectus has previously reported, based on rapid tumor destruction in a positive Phase 2 trial in melanoma patients receiving PV-10 (protocol PV-10-MM-02), input from the Agency regarding the current development plan was sought. Agency guidance (Frequently Asked Questions: Breakthrough Therapies) encourages sponsors to seek such advice prior to formal request for designation.
Chief Executive Officer Craig Dees, Ph.D., observed, “This meeting with the FDA is another significant step forward in streamlining the pathway to initial U.S. approval of PV-10 as the first local agent for recurrent locoregionally advanced melanoma. These patients suffer with troublesome, disfiguring disease that can persist for many years before presenting at distant sites. Our meeting with the Agency established the parameters for submission of a BTD request tailored to addressing the pressing needs of these patients. We’re grateful that our work with the Agency, in this and in our previous meetings, to identify a strategy for demonstration of clinical benefit in recurrent patients is bearing fruit. We are very pleased that the path to initial approval in the U.S. is now clear and PV-10 can be available to help patients in a more condensed time frame than if the Agency required an overall survival endpoint in a large randomized Phase 3 study.”
The meeting and official meeting minutes provided valuable guidance on a number of issues surrounding the approval path of PV-10:
The Agency agreed with Provectus that treatment of cutaneous and subcutaneous tumors in patients with locally advanced cutaneous melanoma (i.e., recurrent, in-transit or satellite melanoma that has not yet spread from the skin to distant sites) could provide clinical benefit to such patients, particularly if the measured objective responses in patients’ disease correlated to a demonstrated treatment effect on one or more symptoms of their disease (e.g., pain, infection or significant bleeding).
The Agency agreed to work with Provectus to quantify symptom control in this patient population.
In reference to discussions on the potential for breakthrough therapy designation, “FDA advised Provectus to provide objective response rates with adequate information to evaluate the symptomatic treatment effects (e.g. pain, infection, bleeding) in patients presenting with locally advanced cutaneous melanoma who received PV-10 to all lesions.”
The Phase 2 study of PV-10 showed:
Among all 80 intent-to-treat melanoma patients, 26% achieved a complete response and another 25% achieved a partial response (shrinkage by at least 30%) of their injected study tumors (51% objective response rate, confidence interval 40-63%).
In the subgroup of melanoma patients that received PV-10 injection into all known disease (28 of the 80 ITT patients), 50% achieved a complete response (71% ORR, CI 51-87%).
In the subgroup of melanoma patients with locally advanced cutaneous melanoma that received PV-10 injection into all known disease or only had 1 or 2 designated bystander tumors untreated (54 of the 80 ITT patients), a complete response was achieved in 232 of 363 injected tumors (64% of lesions) with the vast majority of these tumors requiring only 1 or 2 injections.
These data show that if a tumor is accessible to PV-10 injection, the drug is likely to destroy that tumor. If approved, PV-10 would be the first tissue-sparing local therapy for recurrent melanoma.
Dees continued, “The Agency may yet recommend and it may be in the best interest of Provectus to undertake a small, short bridging study in patients where all tumor burden can be injected. This would allow more frequent dosing than was permitted in the Phase 2 study, presumably akin to the dosing schedule currently used to treat nearly 100 patients under our expanded access protocol, and allow symptomatic endpoints to be prospectively correlated with objective response criteria. Provectus has $18 million in cash reserves and would not require additional capital or the resources of a partner to conduct such a study. If such a study is conducted, it also fits with needs for an international study supportive of licensure in Australia, Europe, China and India.”
Dees further stated, “Non-specific local treatments that temporarily reduce tumor burden, such as surgery and radiation, are the most commonly used cancer therapies today. Furthermore, we believe our clinical and immunologic mechanism data show that it may be possible to delay or prevent melanoma metastasis to distant sites.”
Dees continued, “Measurement of tumor shrinkage via objective response criteria has been considered direct clinical benefit in drug approvals for other skin cancers and we believe a similar case can be made for PV-10 in locally advanced cutaneous melanoma. As advised by the Agency, we will submit data from the 28 patients in our Phase 2 study who had all existing disease treated in a formal BTD request this quarter, and should receive a decision within 60 days of receipt of that request.”
Dees concluded, “While the rapid ablative effect immediately evident in patients treated with PV-10 highlights our path to initial approval, the bystander effect continues to be of scientific interest and studies to quantify systemic tumor-specific immune response in cancer patients are ongoing. This emerging understanding of the secondary effect of tumor ablation with PV-10 is an important foundation for future studies to assess the long-term impact of PV-10 on distant metastasis and possible combination strategies for use of PV-10 in the treatment of cancer patients with more advanced disease.”
About Provectus Biopharmaceuticals, Inc.
Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. Its dermatological drug PH-10 also targets abnormal or diseased cells, with the current focus on psoriasis and atopic dermatitis. Provectus has recently completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus please visit the Company's website at www.pvct.com or contact Porter, LeVay & Rose, Inc.
FORWARD-LOOKING STATEMENTS: The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date thereof.
Copyright Business Wire 2014
Source: Business Wire (January 24, 2014 - 12:09 PM EST)
News by QuoteMedia
www.quotemedia.com
MNTR Yeh SM I caught the news but
couldnt catch this SOB. I gave up at .60 OH well could be worse I could be holding 2.90's lolol
Mentor Capital Says HempCon to be First Funded from New Public Cannabis Fund
W T F up 850%
1:40 PM ET 1/17/14 | BusinessWire
Mentor Capital, Inc. (OTC Markets:MNTR) announced its first major acquisition for cannabis funding will be HempCon, Inc. That medical marijuana convention company is hosting hemp industry pioneers at the San Jose Convention Center January 17-19th. The agreement by principals and letter of intent outlines that HempCon, Inc. will receive $7.0 Million from Mentor Capital investors plus future public market appreciation for a 100% interest. Positioning HempCon to be the first to be funded by the first operating public cannabis fund of its kind should be wholly credited to savvy action by HempCon founder Edwin Kwong, who had already been approached by two other public companies, reports Mentor Capital CEO Chester Billingsley.
Those merger discussions between the CEOs are a snapshot of the turning page in the marijuana industry as it shifts from a movement to a financed business. Sober bankers now meet with serious founders and provide substantial capital for reward, expansion and roll-up. Quickly shifting Mentor Capital's authorization for shareholders to directly purchase $140 million in now cannabis related shares, gives other cannabis founders and the interested public a timely opportunity to participate in this market from a fresh start. To endorse confidence in his long-term investment focus the Mentor CEO has placed his shares in a voluntary escrow.
"Mentor has a medical history and is most interested in the positive effect of cannabis slowing the electric signal at the synapse - meaning, it calms things," explains Billingsley. "Nausea is settled, seizures don't build to a cascade, shaking is smoothed and pain is reduced. On the side of social use, we note that marijuana is only half as addicting as alcohol, you can't overdose, people don't fight and they actually drive slower. Drunkenness is reduced by a substitution effect, and the social and fiscal costs of incarceration are reduced," he concludes.
Mentor Capital, Inc., an operating company, by acquisition or investment, seeks to fund a significant portion of the $140 Million that would flow from the exercise of warrants its shareholders already hold into leading cannabis brands. Mentor Capital emphasizes legal compliance and its CEO's shares are held in escrow. www.MentorCapital.com.
Forward Looking Statements, Safe Harbor and Risk Descriptions are Incorporated by Reference from the MNTR Company Web Site above.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20140117005773r1&sid=cmtx6&distro=nx
SOURCE: Mentor Capital, Inc.
Mentor Capital, Inc.
Chester Billingsley, CEO
760-788-4700
Amarantus BioScience “2014: Initiation of Eltoprazine Phase 2b and LymPro Commercialization”
Amarantus BioScience, Inc. (OTCQB: AMBS) published a new blog post on The Chairman’s Blog, written by the company’s CEO, Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that provides key executive officers and key opinion leaders a unique platform to share insights about company and industry trends.
Amarantus CEO, Gerald Commissiong, reflects on the effect the recently announced in-licensing of Eltoprazine for Parkinson’s disease will have on the company’s value. With increased focus on the company’s pipeline, Mr. Commissiong sees it as “an opportunity for the public to review [Amarantus’] pipeline and become familiar with [Amarantus’] LymPro diagnostic blood test for Alzheimer’s disease (AD).” Read his full blog post on TheChairmansBlog.com (http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/2014-initiation-eltoprazine-phase-2b-lympro-commercialization/)
About Amarantus
Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test (“LymPro Test®”) for Alzheimer’s disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson's disease (“NuroPro”) and the discovery of neurotrophic factors (“PhenoGuard”). For further information please visit http://www.amarantus.com/, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.
About TheChairmansBlog.com
TheChairmansBlog.com is an exclusive, online media publication where publically and privatively held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. In addition to management`s insightful blog posts, TheChairmansBlog.com staff and aggregate partners contribute articles on finance, technology, health, and energy while providing updated market trends, news, and information.
Source: Accesswire IA (January 17, 2014 - 12:23 PM EST)
News by QuoteMedia
www.quotemedia.com
SmartMetric to Launch World's First Bitcoin Card With Biometric Fingerprint Protection
10:16 AM ET 1/10/14 | Marketwire
SmartMetric, Inc. (OTCQB: SMME), a developer of patented biometric products, announced today it has developed and will soon launch the SmartMetric Biometric Bitcoin Card, the world's first biometric, fingerprint secured, off-line storage platform for bitcoins.
"SmartMetric's bitcoin card can significantly accelerate the growth and rate of adoption for bitcoins as the new global currency. By applying our patented biometric technologies to a bitcoin payment card, we offer the world's first fingerprint-secured method to safely store and use bitcoins," stated SmartMetric President and CEO Chaya Hendrick.
The SmartMetric Biometric Bitcoin Card uses the Company's patented biometric fingerprint technology, the world's smallest fingerprint reader. The card offers the benefits of bitcoins such as peer-to-peer transactions and card-to-card direct bitcoin sending anywhere in the world, while enabling real-time, in-person standard payment transactions at merchants and compatibility with standard ATMs around the world. Advanced patented fingerprint technology uses the cardholder's unique biometrics to lock and unlock the SmartMetric Biometric Bitcoin Card, providing safety and discrete portability.
Bitcoins are becoming more widely used around the world, driven by government non-intervention and merchant and consumer demand. In the U.S., Federal Reserve Chairman Ben Bernanke recently sent a letter to the Senate noting that bitcoin may "hold long-term promise... if the innovations promote a faster, more secure and more efficient payment system." Japan, Germany, and Singapore have also recently taken an open stance on bitcoin, choosing to keep the digital currency unregulated for the time being.
According to www.blockchain.info there are an estimated 12 million bitcoins in circulation today. With Bitcoins trading at approximately $925 per bitcoin on January 6, 2013, there is an estimated $11 billion worth of bitcoins in circulation.
About SmartMetric
SmartMetric, Inc. (OTCQB: SMME) develops patented biometric technologies used for security and identification, including the world's smallest fingerprint reader. The Company's proprietary advanced miniature electronics technology uses sub-micro computers to create fingerprint and security applications that were not previously possible. The world's smallest fingerprint reader is designed to fit inside standard payments cards as well as ID cards. Because of the miniature size of the electronics it is ideal for use in a broad array of products requiring an enhanced identification system. SmartMetric's products include biometric credit card and biometric debit card technologies, a medical emergency biometric card, and a MedicalKeyring(TM). For information on SmartMetric and its technology please go to www.smartmetric.com.
Safe Harbor Statement Certain of the above statements contained in this press release are forward looking statements that involve a number of risks and uncertainties. Such forward looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Readers are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those indicated in the forward-looking statements as a result of various factors.
Investor Relations:
Jens Dalsgard
ConstellationAA.com
+1.775.771.5808
SmartMetric, Inc.
Chaya C. Hendrick
President & CEO
+1.786.269.2238
ceo@smartmetric.com
SOURCE: SmartMetric, Inc.
Endexx to Track a Million Pounds of Medical Marijuana in Canada
12:31 PM ET 1/9/14 | Marketwire
Endexx Corporation (OTC Pink: EDXC) to track and support through its M3 technology services up to 1.3 million pounds of Medical Marijuana annually for CEN Biotech, a division of Creative Edge Nutrition, Inc.(OTC Pink: FITX). Health Canada enacted in December 2013 new regulations for the production and distribution of medical marijuana for the Canadian market under the "Marihuana for Medical Purposes Regulations" (MMPR), setting the rules for licensed commercial producers to grow, process and distribute marijuana products directly to marijuana patients and medical providers.
MMRP outlines tracking, recording and reporting requirements, in relation to transactions, client registration, security, production and inventory that licensed producers need to meet for compliance.
M3Hub Seed to Sale Tracking platform is ready to enter the Canadian medical Marijuana market through a contractual agreement entered between Endexx and CEN Biotech, a division of Creative Edge Nutrition (OTC Pink: FITX) last November. CEN Biotech is expected to receive license to grow, and be able to export, up to 1.3M lbs. of marijuana products annually on a ten acre facility in Canada as of April 1, 2014.
Bill Chaaban, President & CEO of CEN Biotech, stated, "After canvassing the market of seed to sale software, we determined that the M3Hub Seed to Sale Tracking platform meets and exceeds the requirements as demanded by our facility and the governing regulatory authorities. These conclusions were made after carefully reviewing the screen shots and live demo of the software."
The M3Hub Seed to Sale Tracking platform meets and exceeds Health Canada's compliance thresholds:
M3Hub creates a web of traceable connections between all the critical touch points in the supply chain processes, tracking all activity from the origin of the seed to germination, cloning, nutrients, pesticide, fungicide, soil management, space conditioning, plant rotation, bud tending, "scrogging," harvesting, drying, processing, packaging, shipping, receiving, and sale to the end user/patient.
M3Hub also integrates security monitoring, personnel ID verification, RFID and barcode technology. The features provide a level of compliance that exceeds government level requirements. The touch points are varied and complex and the M3Hub platform offers the quickest path for licensed producers to efficiency and compliance and gives them the tools to optimize quality control, yield, growth cycles, strain management, processing, packaging and client management.
The M3Hub supply chain management system is integrated seamlessly between growers, processors and retailers. As applied to the Seed to Sale cycle, M3Hub has been shown to increase overall process efficiencies and productivity by up to 40% through accelerated crop cycles, reduced labor costs, improved product quality, inventory control, process management, improved customer experience and regulatory compliance.
M3Hub system components have been utilized in the trucking and shipping industries, agriculture grow operations, pharmaceuticals, CRM and POS applications for the past 10 years. The systems have been customized to uniquely provide the controls necessary to manage all medical marijuana processes and features down to their smallest components and derivatives.
A variable set of applications provides a complete set of services for each type of operation along the supply chain and each can be customized to the specific needs of growers, processors and vendors. These applications include:
View data
-- User Account Management -- Business Definition -- Inventory Management -- Sales Management -- Shipping/Transfer Tracking -- Reporting -- Data Tracking -- Customized Automation -- Regional Data Management -- Point of Sale or Final Transaction Assistance
M3Hub plans to expand its collaboration efforts with producers in new legalized markets both in the US and internationally and develop Seed to Sale management solutions that are market specific, adaptable for international trade, scalable, secure and compliant and will ultimately provide standardization for the Cannabusiness Industry.
About Endexx : www.endexx.com, www.gsgsolar.com, www.m3hub.com, www.autospense.com, www.THCFinder.com
Endexx Corporation is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software developers, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. Endexx's team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.
The Endexx management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Endexx Corporation is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.
Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com.
http://www.otcmarkets.com/stock/EDXC/quote
Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Contact:
Todd Davis
endexx@endexx.com
SOURCE: Endexx Corporation
Amarantus BioScience CEO Publishes New Blog Entitled “Unlocking Shareholder Value as Milestones Approach: Uplisting in 2014"
Amarantus BioScience, Inc. (OTCQB: AMBS) published a new blog post on The Chairman’s Blog, written by the company’s CEO, Gerald Commissiong. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Amarantus CEO, Gerald Commissiong, writes about the key milestones the company expects to achieve in 2014 to improve shareholder value. Read his full blog post on TheChairmansBlog.com (http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/unlocking-shareholder-value-milestones-approach-uplisting-2014/)
Merry Christmas ATS !!!
Alanco Wins Landmark County Approval for Western Colorado’s First Oil & Gas Waste Disposal Landfill to Include Naturally-Occurring Radioactive Material (NORM) O&G Wastes
Alanco Technologies, Inc. (OTCBB: ALAN) announced that on December 10, 2013, the Mesa, Colorado County Board of Commissioners unanimously approved a proposal for the Company’s Alanco Energy Services (AES) subsidiary to construct and operate on its 160 acre Indian Mesa site near Grand Junction, Colorado, an 80 acre, 3 million cubic yard capacity landfill for disposal of solid oil & gas (O&G) waste, such as drill cuttings, tank bottoms, sock filters, etc. Significantly, the landfill approval also allows for disposal of Naturally-Occurring Radioactive Material (NORM) contaminated O&G wastes, including both solids and produced water. This new County landfill approval is in the form of an amendment to AES’s initial Indian Mesa permit issued in 2010 approving produced water disposal utilizing evaporation ponds.
AES expects final construction approval from the Colorado Department of Public Health and Environment (CDPHE) in February 2014 for Indian Mesa’s produced water disposal ponds, which will consist of 12 ponds on the north 80 acres of the 160 acre site with an annual evaporative capacity in excess of 1 million barrels of produced water. Construction approval for Indian Mesa’s south 80 acre landfill operation is expected by fall 2014. Completed build-out of the Indian Mesa facility, including both landfill and evaporative ponds, will result in a unique Western Colorado “one stop shop” for all O&G waste products, including NORM contaminated waste streams.
Update: AES’s Deer Creek Facility
Now over one year in commercial operation, AES’s Deer Creek produced water disposal facility, located approximately 4 miles southeast of the AES Indian Mesa site, with evaporative capacity of approximately 300,000 barrels annually, is providing Piceance Basin producers with outstanding service and significant transportation cost savings.
Further improvement in AES’s Deer Creek customer service capability was facilitated on November 12, 2013 by the Mesa County Board of Commissioners approval of an amendment to Deer Creek’s County Use Permit, allowing 24/7 operation versus the previously restricted daylight hours only, and no Sunday operation. The new 24/7 operating permit proved its value on Sunday, December 15, 2013, when the Deer Creek facility recorded and processed a record 38 truckloads of produced water, averaging 130 barrels per truck.
Bob Kauffman, Alanco CEO, commented, “While Mesa County’s unanimous approval of our proposed Indian Mesa landfill is a very important milestone in our development of AES’s Colorado O&G waste disposal business, the inclusion of NORM disposal capability may well prove to be the pivotal outcome. The State of Colorado is in the forefront of recent activity to develop new regulations for permanent disposal of NORM contaminated waste products, most particularly O&G waste materials due to volume and projected growth. We believe that new, more restrictive NORM regulations will be imposed on Colorado oil and gas producers within 12-18 months, which will result in a multi-million dollar market opportunity for approved, logistically attractive NORM O&G disposal facilities. Currently, the only disposal site in the State of Colorado permitted to receive NORM waste is Clean Harbor’s Deer Trail facility in Eastern Colorado. Indian Mesa is anticipated to be the first 'one stop shop' NORM O&G disposal facility in Western Colorado serving Piceance Basin producers, and poised to provide exceptional future value to both potential customers and AES.”
EXCEPT FOR HISTORICAL INFORMATION, THE STATEMENTS CONTAINED IN THIS PRESS RELEASE ARE FORWARD-LOOKING STATEMENTS MADE PURSUANT TO THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. ALL SUCH FORWARD-LOOKING STATEMENTS ARE SUBJECT TO, AND ARE QUALIFIED BY, RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE EXPRESSED OR IMPLIED BY THOSE STATEMENTS. THESE RISKS AND UNCERTAINTIES INCLUDE, BUT ARE NOT LIMITED TO, REDUCED DEMAND FOR OUR PRODUCTS; COMPETITIVE PRICING AND DIFFICULTY MANAGING PRODUCT COSTS; DEVELOPMENT OF NEW TECHNOLOGIES; RAPID INDUSTRY CHANGES; FAILURE OF AN ACQUIRED BUSINESS TO FURTHER THE COMPANY’S STRATEGIES; THE ABILITY TO MAINTAIN SATISFACTORY RELATIONSHIPS WITH LENDERS AND REMAIN IN COMPLIANCE WITH FINANCIAL COVENANTS AND OTHER REQUIREMENTS UNDER CURRENT BANKING AGREEMENTS; AND MARKET RISK ASSOCIATED WITH HOLDING ORBCOMM STOCK.
Copyright Business Wire 2013
Source: Business Wire (December 17, 2013 - 2:51 PM EST)
News by QuoteMedia
www.quotemedia.com
InterCore's Alertness Detection Software Could Avert Future Disasters Like the MTA Derailment
1:44 PM ET 12/17/13 | Marketwire
InterCore Energy, Inc. (OTC Pink: ICOR) believes that the alertness detection technology it is commercializing will likely prevent future disasters like the recent derailment of the Metro-North commuter train.
InterCore's ADS(TM) System detects and signals an operator's impending loss of alertness sufficiently in advance -- generally 45 minutes to two hours before the onset of sleep -- so that appropriate action can be taken well in advance of the operator becoming a hazard to himself and others. The ADS(TM) System utilizes biometric monitoring of multiple points on an operator's head -- eyes, nose, chin, and other features -- to evaluate when his level of alertness is diminishing or has become impaired, long before he feels such a loss of alertness. In applications such as truck or train operations, the ADS(TM) System would provide visual and audible alerts of the operator's impending loss of alertness to both the operator and the dispatch control center.
"The recent Metro-North commuter train accident brings into sharp focus the need for technologies that can detect deteriorating alertness, and ideally doing so without a significant impact on costs and productivity. Many of the approaches that are now becoming popular in motor vehicles monitor abnormal conditions such as lane departures, steering wheel movements, eye closures, and other parameters. However, the result is that they tell the operator of a vehicle or equipment something he probably already knows -- he's falling asleep," said James F. Groelinger, a director of InterCore. He continued: "In contrast, the ADS(TM) System provides alerts long before the operator realizes he is becoming drowsy, and well before his level of alertness becomes impaired. Our system, which was developed in conjunction with electroencephalograms of drivers in real and simulated driving conditions, provides alerts 45 to 120 minutes prior to the onset of actual sleep."
In this way, the ADS(TM) System enables preventive steps to be taken long before an operator represents a risk to himself or others. In a situation like the recent MTA tragedy, the ADS(TM) System would likely issue warnings to the engineer and to the train control center one or more station stops before a dangerous curve or other hazardous situation is encountered. Such a warning would enable preventive measures to be taken, possibly including the dispatch of a relief operator to take over the controls, thus averting the disaster.
The ADS(TM) System, deployed as a smartphone app by InterCore's wholly-owned Canadian subsidiary, SRG Inc., has been in development for more than a decade. Currently it is in a commercial demonstration program in more than 1,500 trucks in Canada. A smartphone and camera are mounted on the dashboard of over-the-road trucks and the ADS(TM) System provides drivers and dispatchers with predictive alerts of the driver's impending loss of alertness up to 2 hours before the potential onset of sleep. For fleet operators, this provides sufficient time for the dispatch center to direct the driver to a safe location to pull off the road and take a rest. This is in contrast to the performance of virtually all other available alertness detection systems, which are merely reactive -- telling a driver that he/she has fallen asleep, offering little or no opportunity for timely preventive actions to be taken.
Mr. Claude Brun, InterCore's CEO, said: "We have completed the migration from the original platform of stand-alone ADS(TM) System units to the exciting smartphone app. The current demonstration program is the first part of our previously-announced arrangement with a major insurance company to implement a program that could involve up to 80,000 vehicles or more starting in the first quarter of 2014. Over the longer term, we see exciting opportunities in a wide variety of other applications, such as power and chemical plants, air traffic control, shipping, personal automobiles, and more."
In July 2013, SRG had announced that a commercial insurance brokerage company in Canada had commenced a 100-vehicle test of the ADS(TM) System that was quickly expanded to 150 vehicles. Subsequently, the brokerage company asked to further expand the demonstration to 600 vehicles. However, since the ADS(TM) System was no longer being produced as a standalone device, this request was deferred in favor of continuing to develop the smartphone app. Since September, 1,500 BlackBerry apps have been activated, and the release of an app compatible with Apple's iOS7 iPhone operating system is imminent.
About InterCore Energy, Inc.
InterCore Energy, Inc. (OTC Pink: ICOR) is a public company focused on the commercialization and deployment of the ADS(TM) System and related products through its subsidiary, SRG, Inc. Designed around proprietary alertness detection technologies, the ADS(TM) System helps alert operators to their work activity capability based on real-time monitoring of their state of alertness. See www.intercoreenergy.com and srgint.com.
Forward Looking Statements
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the U.S. Securities and Exchange Commission via the Edgar system. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved.
Contact:
James F. Groelinger
jgroelinger@icorinc.com
InterCore Energy, Inc.
201-512-8732
www.intercoreenergy.com
www.srgint.com
SOURCE: InterCore Energy, Inc.
Global Green Inc.’s Salmonella Vaccine Meets FDA Food Policy of Phasing Out Antibiotics on Farms
Global Green, Inc. (OTCBB:GOGC), a green bio-pharmaceutical company, today announced that in a major shift of national food policy, the Food and Drug Administration (FDA) is phasing out the non-medical use of antibiotics on farm animals in an effort to combat growing human resistance to the crucial drugs. Antibiotic-resistant superbugs are on the rise as overuse of antibiotics raises the risk of microbes evolving resistance and eventually spreading to humans.
The plan, announced December 11, is intended to limit the use of antibiotics to treat sick animals, and the elimination of drugs to promote faster growth. "It is important to use these drugs only when medically necessary," the FDA said on its website. They are asking companies that produce drugs for animals to voluntarily change their labels, no longer advertising improved growth and feed efficiency from antibacterial drugs.
Salmogenics™, Global Green’s patented Salmonella vaccine for poultry, meets the FDA’s policy of phasing out antibiotics on farms. Antibiotics are frequently used on farm animals to promote growth. Studies showed that Salmogenics helped chickens increase in weight without the use of any antibiotics. The Salmogenics vaccine is injected into the egg, before the chick is hatched, improving the immune system, health and welfare of the chicken from the first day of age, cost-effectively providing a healthier source of protein for humans.
Dr. Mehran Ghazvini, DC, NMD, Chairman and CEO stated, “Poultry growers are diligently working with the FDA. We recognize their commitment and their efforts to produce healthy protein sources for consumers.”
“One of the reasons antibiotics are overused is due to the benefit of the chicken gaining weight. In our studies, we showed Salmogenics can help chickens gain .126 pounds more weight per chicken which is equal to 5 billion 40 million more pounds of chicken worldwide. I believe we have the solution to this problem to help growers meet the FDA requirements to use the antibiotics just to defend against the disease,” Dr. Ghazvini concluded.
The European Food Safety Authority announced that antibiotics have been widely used in animal production for decades worldwide. The Commission decided to phase out, and ultimately ban in 2006 the marketing and use of antibiotics as growth promoters in feed. This decision was based on opinions from the Scientific Steering Committee, which recommended the progressive phasing out of antibiotics used for growth stimulation, while still preserving animal health.
CNN reported that farms consume about 80% of the nation's antibiotics supply. About 29.9 million pounds of antibiotics were sold in 2011 for meat and poultry production, compared to 7.7 million pounds sold for human use, according to the Pew Charitable Trusts.
Preferring a voluntary approach, the FDA wants to hear from companies within three months about their plans to change labels and will give them three years to put them in place.
About Global Green, Inc.
Global Green, Inc. is a green bio-pharmaceutical company committed to identifying technology platforms and commercializing vaccines that contain natural organisms that are not genetically modified, utilizing pharmaceutical standards without the use of mercury. For more information, visit www.globalgreeninc.com.
Forward-Looking Statement:
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties which include, among others, the inherent uncertainties associated with smaller reporting companies including, without limitation, other risks detailed from time to time in the Company’s periodic reports filed with the SEC.
Copyright Business Wire 2013
Source: Business Wire (December 17, 2013 - 12:40 PM EST)
News by QuoteMedia
www.quotemedia.com
Court Confirms Patriot Coal's Plan Of Reorganization
11:02 AM ET 12/17/13 | PR Newswire
Patriot Coal Corporation (OTC: PCXCQ) today announced that the U.S. Bankruptcy Court for the Eastern District of Missouri has confirmed the Company's Plan of Reorganization. Patriot will close on its exit financing, complete the rights offerings and emerge from Chapter 11 reorganization on December 18.
"This marks the final step in Patriot's financial restructuring," commented Patriot President and Chief Executive Officer Bennett K. Hatfield. "We look forward to a new beginning as a well-capitalized company providing a competitive product to the electric utility and steel industries."
About Patriot Coal Patriot Coal Corporation is a producer and marketer of coal in the eastern United States, with 10 active mining complexes in Appalachia and the Illinois Basin. Patriot ships to domestic and international electricity generators, industrial users and metallurgical coal customers, and controls approximately 1.8 billion tons of proven and probable coal reserves.
Forward-Looking Statements Certain statements in this press release are forward-looking as defined in the Private Securities Litigation Reform Act of 1995. These statements involve certain risks and uncertainties that may be beyond the Company's control and may cause actual future results to differ materially from current expectations. The Company undertakes no obligation (and expressly disclaim any such obligation) to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Factors that could affect the Company's results include, but are not limited to: the ability of Patriot and its subsidiaries to continue as a going concern; coal price volatility and demand; the outcome of commercial negotiations involving sales contracts or other transactions; employee attrition and the Company's ability to retain senior management and key personnel; U.S. and international financial, economic and political conditions, including coal, power and steel market conditions; availability and prices of competing energy resources for electricity generation; geologic, equipment and operational risks associated with mining; the ability to successfully implement solutions to treat effluent selenium exceedances; actual costs of complying with selenium effluent limits; reductions of purchases or deferral of shipments by major customers; changes in the interpretation, enforcement or application of existing and potential laws and regulations affecting the production of the Company's coal; environmental laws and regulations, including those affecting the Company's operations and those affecting customers' coal usage; labor availability and relations; availability and costs of credit, surety bonds and letters of credit; weather patterns and conditions affecting energy demand or disrupting supply; regulatory and court decisions including those impacting permits issued pursuant to the Clean Water Act; developments in greenhouse gas emissions regulation and treatment; the outcome of pending or future litigation, changes in the costs to provide healthcare to eligible active employees and certain retirees under postretirement benefit obligations; increases to contribution requirements to multi-employer retiree healthcare and pension plans; customer performance and credit risks; inflationary trends; downturns in consumer and commercial spending; supplier performance and the availability and cost of key equipment and commodities; availability and costs of transportation; the Company's ability to respond to changing customer preferences; the effects of mergers, acquisitions and divestitures; competition in the coal industry; and the Company's ability to replace coal reserves. In the event that the risks disclosed in Patriot's public filings and those discussed above cause results to differ materially from those expressed in Patriot's forward-looking statements, Patriot's business, financial condition, results of operations or liquidity, and the interests of creditors, equity holders and other constituents, could be materially adversely affected. For additional information concerning factors that could cause actual results to materially differ from those projected herein, please refer to Patriot's Form 10-K and Form 10-Q reports.
SOURCE Patriot Coal Corporation
http://rt.prnewswire.com/rt.gif?NewsItemId=CG34501&Transmission_Id=201312171102PR_NEWS_USPR_____CG
SKTO's Medical Greens Announces Start of Distribution of Dharmanol December 13, 2013 - 12:52 PM EST
SK3 Group, Inc's (OTC Pink: SKTO) - subsidiary Medical Greens is pleased to announce that the first batch of Dharmanol has been manufactured and is ready to be rolled out for California distribution.
Dharmanol (pronounced DAR-mah-nol) will be available in two forms: low-dose, non-psychoactive tablets and high-doses directed to cancer.
The low-dose, non-psychoactive tablets can be taken daily as a nutritional supplement to stimulate the endo-cannabinoid system, an internal system which controls and regulates many other bodily systems such as immune response. Much research has shown that there is substantial medicinal benefit in "stimulating" a compromised endo-cannabinoid system with cannabinoids, causing the other systems to work as they should.
At the opposite end of the spectrum is using Dharmanol for cancer. Very large doses can be taken daily with no psychoactive effects. On observing the spectacular results that patients are receiving with standard Simpson therapy, most scientists studying cannabis medicine agree that if the dose could be increased ten or a hundred times, its already substantial efficacy will be greatly increased. Now this is possible thanks to the removal of the "high" from the cannabinoids in the production of Dharmanol.
These tablets contain an array of the most beneficial non-psychoactive cannabinoids. Each tablet will contain 5 mg. of CBD, 5 mg. of mixed cannabinoids in their non-psychoactive form (known as mixed carboxylates) and 5 mg. of a steam-distilled mixture of the natural terpenes and terpenoids found in cannabis and hemp. The terpene element is thought to be responsible for the increased medicinal efficacy of "whole plant" cannabis preparations. The specific recipe is proprietary to Medical Greens.
"These products are game changers for patients," said SKTO President Artemus Mayor. "Now patients can accurately regulate their dosing with medication, without any worry of the psychoactive effects, or high, that is the natural byproduct of existing products on the market. We are fortunate that our team has been among the first to be able to enhance the consumer, and patient, experience in this manner."
About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease. Use only as directed.
SK3 Group, Inc.
Investor Relations
investors@medicalgreens.com
SOURCE: SK3 Group, Inc.
Source: eTeligis (December 13, 2013 - 12:52 PM EST)
News by QuoteMedia
www.quotemedia.com
MagneGas Files Provisional Patent Application
11:18 AM ET 12/13/13 | PR Newswire
MagneGas Corporation ("MagneGas" or the "Company") (NASDAQ: MNGA), the developer of a technology that converts liquid waste into a hydrogen-based fuel announced today that it has filed a provisional patent application titled "An Apparatus for Flow-Through of Electric Arcs" on the 3rd generation design of MagneGas sterilization and gasification systems.
"MagneGas continues to strengthen its Plasma Arc Technology patent portfolio through ongoing R&D and in-field application learning. This next generation system utilizes improved design flows to have an even smaller footprint and process a more versatile liquid feedstock," remarked Executive Vice President of Operations, Jack Armstrong.
"The suite of MagneGas patents are based on the inherent efficiency and safety of a submerged plasma arc design and we are proud of our new versatile system," commented Ermanno Santilli, CEO. "By making the unit smaller and refining the flow design, we were able to better control the liquid stream and expand our ability to process various feedstock. We are developing larger scale prototypes and look forward to commercialization in early 2014."
The MagneGas IR App is now available for free in Apple's App Store for the iPhone or iPad http://bit.ly/AfLYww and at Google Play http://bit.ly/Km2iyk for Android mobile devices.
To be added to the MagneGas investor email list, please email pcarlson@kcsa.com with MNGA in the subject line.
About MagneGas Corporation Founded in 2007, Tampa-based MagneGas Corporation (NASDAQ: MNGA) is the producer of MagneGas, a natural gas alternative and metal working fuel that can be made from certain industrial, municipal, agricultural and military liquid wastes following the receipt of appropriate governmental permits.
The Company's patented Plasma Arc Flow process gasifies liquid waste, creating a clean burning hydrogen based fuel that is essentially interchangeable with natural gas. MagneGas can be used for metal working, cooking, heating, powering bi fuel automobiles and more. For more information on MagneGas, please visit the Company's website at www.MagneGas.com.
FORWARD-LOOKING STATEMENTS This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The Company is currently using new ethylene glycol to produce fuel until proper permits to process used liquid waste have been obtained. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.
SOURCE MagneGas Corporation
http://rt.prnewswire.com/rt.gif?NewsItemId=CL33275&Transmission_Id=201312131118PR_NEWS_USPR__
Nellymoser and NeoMedia Announce a Complete Solution for Migrating from Microsoft Tag to Other Activation Technologies
1:08 PM ET 12/12/13 | BusinessWire
Nellymoser and NeoMedia Technologies, Inc. (OTC BB:NEOM) announced today a solution that will allow a seamless migration from Microsoft Tag ("Tag") to other forms of mobile activations such as QR codes, watermarks, and image recognition (IR). Similar to QR codes, Microsoft Tag is a technology for triggering activations from traditional or digital media, including print.
Since Tag is being discontinued by Microsoft, customers looking for new or alternative solutions to migrate their codes now have a choice. Microsoft Tag, which held an 84% market share in the Top 100 magazines in 2010, has been eclipsed by QR codes, which comprised 68% of all mobile activations in 2012.
The joint solution by Nellymoser and NeoMedia presents brands, publishers, and agencies with options to migrate from Tag to a wide range of activation technologies such as QR, other 2D codes, or watermarks. The migrated content can be scanned with the free NeoReader(R) app or a branded companion app using a built-in universal scanner. Robust analytics and end-to-end client-specific options are some of the joint solution's benefits. Incentive offers are in place until March 31, 2014.
"Nellymoser has been the go-to company for innovative print to mobile experiences driven straight-off-the page for both magazine editorial programs and advertising," said Laura Marriott, Chief Executive Officer of NeoMedia. "Our partnership - between two of the industry's pioneers and leaders in mobile marketing - allows us to offer a complete solution based on best practices gathered from both companies' expertise."
"Neomedia is one of the earliest QR companies with the most complete 1D and 2D scanning capabilities. Their large services install base is backed by solid IP ownership," said John Puterbaugh, EVP and Chief Digital Officer of Nellymoser. "Together, the companies offer publishers easy-to-implement and market-proven solutions for moving beyond Microsoft Tag."
About NeoMedia
NeoMedia Technologies, Inc. (http://www.neom.com) is the pioneer in QR and mobile barcode technology and infrastructure solutions that enable the mobile barcode ecosystem worldwide. Its solutions have transformed approximately 40 million mobile devices with cameras across 193 countries into barcode scanners, enabling a range of practical and engaging applications.
About Nellymoser
Nellymoser (www.nellymoser.com), a mobile marketing and technology company founded in 2000 and headquartered in Boston, creates mobile companion apps and cross-media campaigns. These campaigns are triggered using smartphones via multiple activation points placed in editorial content, advertisements or on product packaging. The result is instant multimedia, interactive and up-to-date content designed to deliver consumer engagement, foster brand loyalty, and drive revenue for clients. Nellymoser's customers include leading publishers, retailers, and brand advertisers.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20131212006124r1&sid=cmtx6&distro=nx
SOURCE: Nellymoser
Nellymoser
Jennifer Bergin, 212-782-7857
Vice President Marketing
jennifer.bergin@nellymoser.com
or
NeoMedia
Candace Vadnais, 303-546-7946
Public Relations
press@neom.com
Cereplast Provides an Update on the Magna Litigation
12:50 PM ET 12/12/13 | GlobeNewswire
Cereplast, Inc. (OTCQB: CERP), a leading manufacturer of proprietary biobased, compostable and sustainable plastics, today is providing an update on the litigation against the Magna Group.
On May 8, 2013, the Company filed in the Southern District of New York a lawsuit against Magna Group LLC and Hanover Holdings LLC for breach of contract, breach of the covenant of good faith and fair dealing. The Action is seeking compensatory damages in an unspecified amount, plaintiff's costs and attorneys' fees, and unspecified equitable or injunctive relief.
Magna Group LLC and Hanover Holdings LLC filed a request for relief and preliminary injunction against Cereplast on August 23. On December 11 the United States District Court - Southern District of New York denied the motion for a preliminary request injunction.
About Cereplast, Inc.
Cereplast, Inc. (OTCQB:CERP) designs and manufactures proprietary biobased, sustainable bioplastics which are used as substitutes for traditional plastics in all major converting processes - such as injection molding, thermoforming, blow molding and extrusions - at a pricing structure that is competitive with traditional plastics. On the cutting-edge of biobased plastic material development, Cereplast now offers resins to meet a variety of customer demands. Cereplast Compostables(R) resins are ideally suited for single-use applications where high biobased content and compostability are advantageous, especially in the food service industry. Cereplast Sustainables(R) resins combine high biobased content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics and packaging. Learn more at www.cereplast.com. You may also visit the Cereplast social networking pages at Facebook.com/Cereplast, Twitter.com/Cereplast and Youtube.com/Cereplastinc.
View data
CONTACT: Cereplast, Inc. Public Relations Nicole Robertson (812) 220 5400 nrobertson@cereplast.com Investor Relations: Alliance Advisors, LLC Alan Sheinwald 914-669-0222 asheinwald@allianceadvisors.net www.AllianceAdvisors.net
http://media.globenewswire.com/cache/15281/small/10386.jpg
http://www.globenewswire.com/newsroom/t
NEWS Wialan Technologies Announces New Director to the Board and Buyback Program
SUNRISE, FL--(Marketwired - Dec 12, 2013) - Wialan Technologies LLC (OTC Pink: ACYD) ("the company"), a next generation wireless telecommunications provider, announced today that the board of directors has appointed James Andrew Connolly III as Board Member and Secretary.
Mr. Connolly is currently President of IBA Capital Funding, Princeton, N.J. He was a founding member of the CEO Council, an organization of executives of smaller public companies. He works as a capital formation specialist with smaller public companies whose securities are traded over the counter and private companies seeking to access the public capital markets. He also invests in these companies. Mr. Connolly has over twenty-five years of experience in Wall Street as a licensed securities broker. Due to his experience in Wall Street, he served on the "Security and Exchange Commission Advisory Committee on Smaller Public Companies."
"I believe Mr. Drew Connolly's experience is a tremendous addition to the company and we are very fortunate to have him onboard," stated Mitch Freifeld. You can read about Drew Connolly in this link: http://secsearch.sec.gov/search?utf8=%E2%9C%93&affiliate=secsearch&query=drew+connolly
In other news, the share buyback program will begin on December 12, 2013 and conclude on December 18, 2013.
The plan, announced on September 20, 2013, calls for the repurchase of shares from the open market in privately negotiated transactions. For the shareholders that would like to sell their shares through the buyback program, the company will accept buyback requests received via certified mail until December 18, 2013. The company will then have 30 days to complete the repurchase.
About Wialan Technologies
Wialan, a next generation Wireless telecommunications provider, is poised for exponential growth from their five years of successful R&D, sales and installations of their impressive WiFi solutions spanning 10 countries. They have established a track record of successful installations in airports, municipalities, apartment buildings, parks, marinas and other locations that require a superior and more robust communication footprint than conventional WiFi providers. Among the outstanding features available with Wialan's wireless 802.11n 300 Mbps solutions is the capability of real-time live color video streaming for many simultaneous end-users, which can help companies with video on demand services to deliver their services wireless without using the Internet.
Safe Harbor: Except for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, risk inherent in the company's domestic and international operations, imprecision in estimating product reserves and the company's ability to replace and expand its holdings. For additional information, visit the websites below or contact the undersigned directly:
Wialan Technologies LLC
http://www.wialan.com
Victor Tapia
Vice-President
Phone: 888-407-7762
Email: partners@wialan.com
Follow us on Facebook at www.facebook.com/WialanTech
Address for Buyback request
10273 NW 46 Street
Sunrise FL 33351
DMH International Provides Update on Merger With Virtual Physician's Network
11:43 AM ET 12/12/13 | Marketwire
DMH International (OTCQB: DMHI), is providing an update regarding their proposed acquisition of Virtual Physician's Network (VPN). On October 21, 2013, DMH International (DMH) announced that they had signed a definitive Letter of Intent to acquire 100% of Virtual Physician's Network (VPN), a medical software and applications provider. On October 30, 2013, DMH announced that the President of VPN, George England, had agreed to become the Chief Executive Officer of the company once the merger is completed. On November 13, 2013, DMH announced that William McCullough and his experienced development team will take over the future software development of DMH, which includes Touch Medical Solutions and Virtual Physicians Network. The acquisition required definitive agreements to be created along with audited financials to be provided by Virtual Physician's Network. This is expected to be completed by the end of January 2014.
"We are very excited about this merger," explained Rik J Deitsch, CEO of DMH International. "Virtual Physician's Network's products are a great addition to our medical imaging and medical records software. They bring entirely new applications and markets to the company as well as seasoned management, software designers and sales support that has been lacking at DMH International," he continued. "The addition of the Virtual Physician's Network's products and management will greatly expand our product offerings and is expected to shorten our time to market for all of our products and services," Deitsch concluded.
Virtual Physicians Network is a mobile healthcare business applications company offering the first fully integrated virtual event and professional networking platform combined with proprietary practice building tools for surgeons, healthcare professionals and medical vendors. Virtual Physicians Network provides all this for through the Virtual Physician's Network mobile app available in the App store (Apple devices), Google Play (Droid devices) and on their web based application. For additional information about Virtual Physician's Network including a video demonstration, visit: www.virtualphysiciansnetwork.com.
"I continue to be excited about the opportunities the merger opens up for both companies" said George England, President and Chief Operating Officer of Virtual Physician's Network. "Virtual Physician's Network was designed with surgeons, healthcare professionals and medical vendors to improve clinical outcomes, save time and money, drive revenue and increase accountability utilizing the latest mobile app technology. By adding the ability to sync with the Touch Medical PACS and EMR software solutions we have the ability to offer a unique and incredible healthcare business application package," he added. "This will greatly accelerate our expansion with surgeons, hospitals and medical vendors by linking these intuitive solutions and compelling content together," Mr. England concluded.
The company recently presented their combined business plan at the Undiscovered Equities conference in Boca Raton. The presentation is available on the Company's website at http://www.dmhintl.com.
About DMH International DMH International, through its subsidiary, Touch Medical Solutions, is a medical software and device company specializing in PACS (Picture Archiving and Communications Systems), EHR (Electronic Hospital records), EMR (Electronic Medical Records), PHR (Personal Health Records), Medical Transcription, and Paperless Medical Office Solutions. For additional information about Touch Medical Solutions, visit: http://www.dmhintl.com
SEC Disclaimer This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in DMH International's ("the Company's") business plan. The merger update with VPN should not be construed as an indication in any way whatsoever of the future value of the Company's common stock or its present or future financial condition. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
Revolutionary Concepts to Develop Ground Breaking Cloud-Based Mobile Alarm Security Services System
Cloud-Based System Could Provide World Wide Mobile and Online Security Services
CHARLOTTE, NC--(Marketwired - Dec 12, 2013) - Revolutionary Concepts Inc., (OTCQB: REVO), a publicly traded company that designs and develops mobile video software and remote security communication systems, announced that it intends to develop and modify its "EyeTalk Communicator" system to deliver it on a cloud- based platform.
The Company is planning to sell and/or license the "EyeTalk" System patents to enable potential users to manage, monitor and control their residential and commercial security system from anywhere in the world. The system would allow for real-time virtual two way audio and visual communications, in streaming video, which could make many existing alarm security monitoring services obsolete. The system could provide remote applications to monitor who's outside or inside your home or business, lock or unlock doors for visitors, photograph and track intruders and notify the police with the information, all in real time.
REVO's President, Ron Carter states, "We feel that if we are successful in developing a cloud-based system, it would be a monumental step in exploring the maximum potential of our patented 'Eye Talk Communicator' system. Imagine being across town, and if some in your family gets locked out of the home, you could visually identity them and remotely let them in safely from a wireless mobile device. You could even take a picture of an intruder and notify the police of their activity. Some have commented that the potential features of the system are similar to some of the technologies seem on feature films such as Star Trek, Total Recall and Minority Report. The EyeTalk system will also interface with smart devices such as iPhone, iPad, BlackBerry and Android. We believe it could interface well with some of the mobile communications technologies being developed by firms such as Google, Amazon, Apple, AT&T, and others. We believe this could provide an unprecedented level of protection and public safety, and be of great benefit to our shareholders."
About Revolutionary Concepts Inc.
REVO is a development stage company that designed and developed the "EyeTalk" Communicator technology, a mobile video, remote smart camera security technology. The system is designed to provide nationwide protection and monitoring of homes and businesses against multiple threats including robbery, fire, theft, burglary and other intrusions through mobile phones, wireless video and remote smart camera security technology. REVO holds patented and patent pending applications that utilize the technology in medical/healthcare, sporting events, child monitoring and several other key areas. Mobile and wireless communications are the major forces driving the "EyeTalk" system technology and represents a new frontier of wireless smart devices for home and business protection. For more information visit www.revolutionaryconceptsinc.com
Safe Harbor Statement - There are matters discussed in this media information that are forward looking statements within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. Such statements are only forecasts and actual events or results may differ materially from those discussed. For a discussion of important factors which could cause actual results to differ from the forward looking statements, refer to Revolutionary Concepts, Inc.'s most recent annual report and accounts and other SEC filings. The company undertakes no obligation to update publicly, or revise, forward looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.
For inquiries contact:
Media Relations
Solomon Ali
704-837-5705
Source: Marketwired (December 12, 2013 - 9:53 AM EST)
Alliance Digital Media Announces Release of the Pinball Arcade for the PlayStation4
4:05 PM ET 12/11/13 | PR Newswire
Alliance Distributors Holding Inc. (Pink Sheets: ADTR), a distributor, developer and publisher of interactive video games and gaming products, today announced that its Alliance Digital Media(TM) unit has released The Pinball Arcade, a video game developed by FarSight Studios for SCEA's new PlayStation®4. The Pinball Arcade may be the most accurate and realistic pinball videogame ever created. The game features pinball tables from Bally®, Williams®, Stern®, Sega®, Data East® and Gottlieb®, to create the ultimate pinball collection.
Key Features Include:
-- DLC - Table Packs, Pro Upgrades, Bundles and Ball Packs released regularly
-- ROM Emulation-100% accurate game play/graphics of real world machines
-- Leaderboards - Bragging rights over friends or all players world-wide for each table
-- Hall of Fame Score - Combined score of owned tables that ranks players
-- Pro Versions - Operator's Menu, Table Exploration, Ball Control, IFPA Pro Tips
-- Table Goals - Accomplishments tied to learning and mastering each table
-- Arcade Play - Single and multi-player games on any of the tables
-- Tournaments - Held on PSN in different ability tiers each month to give players a
-- world-wide tournament ranking.
-- Dynamic lighting cast from every light on the table
-- Real-time lighting, shadows, reflections of 100's of lights per table
-- Social Media integration
-- Motion and Touch controls
-- Stereoscopic 3D support
Jay Gelman, Chairman and Chief Executive Officer, said, "FarSight Studios is a respected developer in our industry. We are delighted to enter into the publishing arena with them on a great family oriented title that utilizes the best features of the PS4(TM) console."
About Alliance Distributors Holding Inc. Alliance Distributors Holding Inc. (www.alliancedistributors.com) is a full-service wholesale videogame distributor, specializing in gaming products and accessories for all key manufacturers and 3rd party publishers. Through its wholly-owned subsidiary, Alliance develops downloadable and social content video games as Metaversal Studios (www.metaversalstudios.com) and publishes videogames as Alliance Digital Media(TM) (www.alliancedigitalmedia.com).
About FarSight StudiosFarSight Studios (www.farsightstudios.com) is a videogame developer located in Big Bear Lake, California. As experienced developers, FarSight Studios has been creating videogames continuously since 1989. They have developed games for every major console from the original Nintendo Entertainment System to the PlayStation®4. FarSight's games have been awarded Editor's Choice awards, Toy of the Year nominations, and Greatest Hits designations on multiple platforms.
Safe HarborCertain statements contained in this press release contain forward-looking statements including without limitation, statements concerning our operations, economic performance, and financial condition. The words "estimate," "believe," "expect," "should" and "anticipate" and other similar expressions generally identify forward-looking statements, which speak only as of their dates.
Investors are cautioned that all forward-looking statements, which are based largely on our current expectations, involve risks and uncertainty. Actual results, events and circumstances (including future performance, results and trends) could differ materially from those set forth in such statements due to various factors, risks and uncertainties, including without limitation, risks associated with technological change, competitive factors and general economic conditions, including the related impact on discretionary consumer spending, changes in marketing and distribution strategies by manufacturers, timely development and release of video game products we produce, potential cost overruns in our development of video games, ability to protect our intellectual property rights, potential claims that we have infringed the intellectual property rights of others, market acceptance of games we develop and / or publish, ability to realize anticipated benefits of acquisitions, potential undiscovered liabilities of companies that we acquire, changes in our business or growth strategy, the emergence of new or growing competitors, various other competitive and technological factors. There can be no assurance that the results referred to in the forward-looking statements contained in this release will occur. The Company has no duty and undertakes no obligation to update any forward-looking information, whether as a result of new information, future developments or otherwise.
Xbox One, Xbox, Xbox 360 and Xbox LIVE are either registered trademarks or trademarks of the Microsoft group of companies.
SOURCE Alliance Distributors Holding Inc.
http://rt.prnewswire.com/rt.gif?NewsItemId=CL31938&Transmission_Id=201312111605PR_NEWS_USPR_____CL31938&DateId=20131211
Seems like pretty good ( real ) news to me. This stock is on absolutely nobodys radar. 13,000 avg daily volume. Wow. Will watch
ProTek Capital, Inc. Advances Clean Technology Focus Without APT Group, Inc.
DALLAS, TX--(Marketwired - Dec 11, 2013) - ProTek Capital, Inc. (OTC Pink: PRPM) ("ProTek") and APT Group, Inc. have mutually agreed to discontinue merger activities.
Earlier this year, ProTek Capital began focusing on the Clean Technology market sector. In August, ProTek entered into a letter of intent to acquire APT, Group, Inc. In October, the two companies entered into a merger agreement. Throughout the course of developing the APT opportunity, ProTek has taken additional steps to streamline its focus on Clean Technology as well as developing other Clean Technology opportunities in addition to APT.
"APT's MotoVox® product line and SmartCarb® patented carburetor technology are good Clean Technology market opportunities," said Edward Vakser, CEO of ProTek Capital, Inc. "In the end, ProTek's corporate platform could not support the necessary investment to advance APT's business plan in a manner that was mutually beneficial to ProTek and APT shareholders. The disengagement is amicable and future opportunities between the two companies may still come about. In the last six months, ProTek steps to enhance and focus the Company's corporate organizational structure and business practices can serve shareholders well as we move forward with the next opportunities in our business development pipeline."
About ProTek Capital, Inc.
ProTek Capital, Inc. has historically concentrated on acquiring a portfolio of unique and promising, high-growth potential companies. The portfolio industry focus has changed and evolved over time and the new acquisitions would represent the next evolutionary step into the burgeoning market for low cost, high efficiency "greener" companies, technologies and IP systems.
Forward-Looking Statements: The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.
CONTACT:
For more information visit:
www.protekcapital.com
ProTek Capital, Inc.
Ev24903@gmail.com
**SGDH** is My New Play for Tomorrow!! Get it on your Radar Now
StockMister
R.I.P. SGD Holdings
Terra Tech Subsidiary Edible Garden To Display at The New York Produce Show and Conference
12:39 PM ET 12/9/13 | GlobeNewswire
Terra Tech Corp (TRTC) subsidiary Edible Garden, a hydroponic herb and produce cultivator, will be displaying their line of living produce at this years New York Produce Show and Conference held in Manhattan between December 10th through 12th. The three-day event will play host to multiple conference sessions, networking opportunities and a trade show featuring over 400 companies catering to buyers representing retail as well as food service.
"It's a phenomenal opportunity for us to show off our line of sustainably cultivated living produce as well as the growth and progress we have made over the year," says Derek Peterson, CEO of Terra Tech Corp. "Events like this allow us to meet and network with buyers giving us an opportunity to expand our brand further throughout the US market. The Northeast is our bread and butter and with the new facility coming on line this month we are excited about having the capacity to expand."
Edible Garden is a premier brand of local and sustainably grown hydroponic produce, currently available at close to 400 major grocery stores such as Shoprite, BJ's Wholesale and others throughout New Jersey, New York, New England, Delaware, Maryland,Connecticut, and Pennsylvania.
About Terra Tech
Terra Tech Corp. (TRTC) through its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. The company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Our complete product line is available at specialty retailers throughout the United States, and via our website. Through its wholly-owned subsidiary Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Food Emporium and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, and Pennsylvania.
For more information on Edible Garden visit: www.ediblegarden.com
For more information about Terra Tech Corp visit: www.terratechcorp.com
Visit us on Facebook @ http://www.facebook.com/terratechcorp
Follow us on Twitter @terratechcorp
Cautionary Language Concerning Forward-Looking Statements
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Terra Tech Corp.'s filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to Terra Tech Corp.'s (i) product demand, market and customer acceptance of its equipment and other goods, (ii) ability to obtain financing to expand its operations, (iii) ability to attract qualified sales representatives, (iv) competition, pricing and development difficulties, (v) ability to integrate GrowOp Technology Ltd. into its operations as a reporting issuer with the Securities and Exchange Commission, and (vi) general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Terra Tech Corp.'s website does not constitute a part of this release.
CONTACT: Bill Clayton
Independence Financial Ltd.
Toll-Free: (888) 603-2896
Email: info@terratechcorp.com
http://media.globenewswire.com/cache/26002/small/19634.jpg
http://www.globenewswire.com/newsroom/ti?nf=MTMjMTAwNjA4NDYjMjYwMDI=
Revolutionary Concepts Mobile Security System Could Dominate the $16 Billion Security Alarm Services Industry
"EyeTalk" System Could Revolutionize the Mobile and Online Security Services Industry
CHARLOTTE, NC--(Marketwired - Dec 9, 2013) - Revolutionary Concepts Inc., (OTCQB: REVO), a publicly traded company that designs and develops mobile video software and remote security communication systems, announced that it has been in talks with one of the world's largest internet related service companies to sell or license its patented mobile product portfolio. Several other companies have expressed strong interest in acquiring REVO'S system, in what many believe could be a revolutionary technology in the $16 billion alarm system service industry.
REVO developed the "EyeTalk Communicator," a wireless mobile video, remote smart camera security technology. The system is designed to provide nationwide protection and monitoring of homes and businesses against multiple threats including robbery, fire, theft, burglary and other intrusions through mobile phones, wireless video and remote smart camera security technology. The "EyeTalk" System is projected to revolutionize the mobile and online security services market by selling a patented system designed to provide an unprecedented level of wireless communication, property protection, interactive services and security solutions. The "EyeTalk" system will interface with smart devices such as iPhone, iPad, Blackberry and Android, and represents the new frontier in the use of wireless smart devices for protection and security.
In the last few years, many large companies have realized the growing power of the internet, wireless technologies and the use of mobile devices to generate higher revenues and profits. This has resulted in significant and substantial amounts of capital being raised and expended to acquire these companies and wireless mobile communication technologies.
On June 19, 2013, Yahoo! Inc., acquired "Tumblr," an internet blog posting website for $1.10 billion. Tumblr was started in 2007, and generated $13 million in revenues in 2012, and $13 million in the first quarter of 2013. According to Yahoo's Form 10-Q Report for June 30, 2013, the $1.10 billion acquisition, included $113 million in liabilities, for a net purchase price of $990.2 million. The acquisition price of $1.10 billion was 84 times Tumblr's $13 million in revenues for 2012.
In August 2012, Facebook Inc. acquired Instagram, a mobile phone-based photo-sharing service. Instagram was started in October of 2012, had 16 employees and reported no revenue at the time of the closing of the transaction. According to Facebook's Form 10-K Annual Report for December 31, 2012, the purchase price of $521 million included $433 million allocated to "goodwill."
Revolutionary Concepts President, Ron Carter states,
"We have been in talks with several companies regarding the acquisition and licensing of our patented system, the talks with this $50 billion multinational internet company appears to be a good fit for us with strong synergies. We're very excited because of the potential marketing of the product through the many internet and wireless based mobile communication channels that they have, and many more that are rapidly developing. If we are successful in completing the transaction of the sale or licensing of our technologies, we may not obtain a price $500 million to $1.10 billion range as in the case of the acquisitions of Tumblr and Instagram; however it does give an indication of the kinds of prices these firms are willing to pay to acquire companies with revolutionary products like ours. Based on our discussions with some of these firms, we believe we could sell or license our patented system in the high multi-million dollar range."
About Revolutionary Concepts Inc.
REVO is focused on the design and development of the "EyeTalk" Communicator technology; a mobile video, remote smart camera security technology. The system is designed to provide nationwide protection and monitoring of homes and businesses against multiple threats including robbery, fire, theft, burglary and other intrusions through mobile phones, wireless video and remote smart camera security technology. REVO holds patented and patent pending applications that utilize the technology in medical/healthcare, sporting events, child monitoring and several other key areas. Mobile and wireless communications are the major forces driving "EyeTalk" system technology. It represents a new frontier of wireless smart devices for home and business protection. For more information visit www.revolutionaryconceptsinc.com.
Safe Harbor Statement - There are matters discussed in this media information that are forward looking statements within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. Such statements are only forecasts and actual events or results may differ materially from those discussed. For a discussion of important factors which could cause actual results to differ from the forward looking statements, refer to Universal Bioenergy Inc.'s most recent annual report and accounts and other SEC filings. The company undertakes no obligation to update publicly, or revise, forward looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.
For inquiries contact:
Media Relations
Solomon Ali
704-837-5705
Terra Tech Distribution Partner GroRite Completes 8000 Square Foot Hydroponic Cultivation Facility, Harvests First Order of Edible Garden Hydroponic Basil 11:42 AM ET 12/6/13 | GlobeNewswire
Terra Tech Corp (TRTC) subsidiary Edible Garden, a hydroponic herb and produce cultivator, signed a distribution deal with GroRite Greenhouse and Garden Centers in May of this year. Under the terms of the agreement Edible Garden and GroRite planned to convert up to 35,000 square feet of greenhouse space at GroRite's retail location in Lincoln Park, New Jersey into a hydroponic cultivation facility. The companies have recently finished converting 8,000 square feet and are currently harvesting and packaging 4,500 living basil plants from the facility. The Edible Garden hydroponic basil will be shipped throughout the Northeast to their current retail partners.
"While finishing the construction of our flagship facility in Belvidere we were also able to complete another step in expanding our cultivation footprint," says Derek Peterson, CEO of Terra Tech Corp. "This facility came on line at the perfect time for us as demand for our products is high throughout the holiday season. We plan to continue converting the remaining 27,000 square feet and expect it to be operational in early 2014."
The Lincoln Park facility is situated within a few hours drive of the New York, New Jersey, and Pennsylvania markets allowing them to efficiently service those areas with Edible Garden's fresh, living and locally grown produce. The operation is also conveniently located near the Hunts Point Produce Market, the largest produce market in the world, which serves an estimated 22 million people within a 50-mile radius. Edible Garden is currently seeding butterhead lettuce in the new space at Lincoln Park for sale and delivery to foodservice wholesalers through the market.
"While our primary focus has been grocers and other specialty retailers, we are beginning to cultivate products for wholesale into the food service industry. Having Manhattan just across the bridge gives us a major marketplace for servicing restaurants, hotels and other foodservice consumers as well," explains Ken Vande Vrede, COO of Terra Tech.
About Terra Tech
Terra Tech Corp. (TRTC) through its wholly owned subsidiary GrowOp Technology specializes in controlled environment agricultural technologies. The company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Our complete product line is available at specialty retailers throughout the United States, and via our website. Through its wholly-owned subsidiary Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Food Emporium and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, and Pennsylvania.
For more information about Terra Tech Corp visit: www.terratechcorp.com
For more information about Edible Garden visit: www.ediblegarden.com
Visit us on Facebook @ http://www.facebook.com/terratechcorp
Follow us on Twitter @terratechcorp
For more information about Edible Garden visit: http://www.ediblegarden.com
Visit Edible Garden on Facebook @ https://www.facebook.com/ediblefarms
Cautionary Language Concerning Forward-Looking Statements
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Terra Tech Corp.'s filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to Terra Tech Corp.'s (i) product demand, market and customer acceptance of its equipment and other goods, (ii) ability to obtain financing to expand its operations, (iii) ability to attract qualified sales representatives, (iv) competition, pricing and development difficulties, (v) ability to integrate GrowOp Technology Ltd. into its operations as a reporting issuer with the Securities and Exchange Commission, and (vi) general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Terra Tech Corp.'s website does not constitute a part of this release.
CONTACT: Bill Clayton
Independence Financial Ltd.
Toll-Free: (888) 603-2896
Email: info@terratechcorp.com
http://media.globenewswire.com/cache/26002/small/19634.jpg
http://www.globenewswire.com/newsroom/ti?nf=MTMjMTAwNjA2ODkjMjYwMDI=
Innovus Pharma Receives Product License Approval of EjectDelay(TM) for Premature Ejaculation From Health Canada
10:00 AM ET 12/6/13 | GlobeNewswire
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced that the Company received the approval of its product license for its over the counter ("OTC") benzocaine-based topical premature ejaculation treatment EjectDelay(TM) in Canada.
"We are thrilled that the product license for EjectDelay(TM) was approved ahead of schedule. The Company is on track to make the product available in as many countries as we can to expand the commercial presence of our product" said Dr. Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. "We are advancing our partnering efforts with a number of interested parties in Canada and we hope to be able to announce our partner on or before the second quarter of 2014" continued Dr. Damaj.
About EjectDelay(TM) and Premature Ejaculation
EjectDelay(TM) is an over-the-counter ("OTC") U.S. Food and Drug Administration and Health Canada compliant proprietary topical treatment containing the drug benzocaine and indicated for delay of premature ejaculation. The drug typically works within minutes of application to the glans of the penis. In clinical trials, the application of benzocaine has been shown to delay premature ejaculation by several minutes. For more information visit www.ejectdelay.com.
Premature ejaculation ("PE") is the most common sexual dysfunction reported by men but is still under-diagnosed and under-treated. PE can happen at any age and its prevalence is consistent across all ages. In an article in The Journal of Sexual Medicine in 2007 Sex Med 2007, D.L. Patrick, D. Rowland and M. Rothman state, "Global studies consistently report that 20-30% of men experience PE worldwide. This means that PE is experienced at similar rates across the globe."
About Innovus Pharmaceuticals, Inc.
Innovus Pharma, headquartered in La Jolla, California, is an emerging pharmaceuticals company that delivers innovative and uniquely presented and packaged health solutions through its over-the-counter medicines and consumer and health products.
For more information, go to www.innovuspharma.com.
INNOVUS PHARMA'S FORWARD-LOOKING Safe Harbor
Statements under the Private Securities Litigation Reform Act, as amended: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the Company, including, but not limited to, receiving patent protection for any of its products, receiving approval or to be compliant with the requirements of any relevant regulatory authority relating to such products, to successfully commercialize such products as EjectDelay(TM) in Canada and other countries and to achieve its other development, commercialization and financial objectives. Readers are cautioned not to place undue reliance on these forward-looking statements as actual results could differ materially from the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's most recent annual report on Form 10-K, subsequent quarterly reports filed on Form 10-Q and other filings made with the SEC. Copies of these reports are available from the SEC's website or without charge from the Company.
CONTACT: Innovus Pharma Contact:
Kevin Holmes
Chesapeake Group
info@chesapeakegp.com
T: 410-825-3930
http://www.globenewswire.com/newsroom/ti?
Thank God. My prayers were answered. Its finally here !!! lololol
NanoTech Entertainment (NTEK) Purchases Sammy Davis, Jr. Personal Collection
NANOTECH ENTERTAINMENT (OTCPINK: NTEK) announced the purchase of a collection of memorabilia, rare audio tapes, and videos from the estate of Sammy Davis, Jr. The collection contains over 2,500 videos, most of which were personally catalogued and labeled by Mr. Davis himself. While some of the music will be licensed to Warner Brothers Music and some items setup for a permanent exhibition at the Rat Pack Museum in Las Vegas, the majority of the content will be available through NanoTech Entertainment’s streaming channels. This Sunday would have marked the remarkable performer’s 88th birthday.
NANOTECH ENTERTAINMENT (NTEK) PURCHASES SAMMY DAVIS, JR. PERSONAL COLLECTION (Photo: Business Wire)
NANOTECH ENTERTAINMENT (NTEK) PURCHASES SAMMY DAVIS, JR. PERSONAL COLLECTION (Photo: Business Wire)
Originally acquired at the “Butterfield & Butterfield” estate auction in 1991 by a collector, the estate was later featured on the History Channel. The individual who bought the collection in 1991 sold it in 2004 to Arthur Mrozowski, CEO of Magic Screen 3D. For many years, Arthur searched for the perfect company to preserve this historic collection. The Sahara Hotel in Las Vegas considered using the collection as a permanent display, but it shut down in 2011. After living in storage for years, Arthur sold the collection to NanoTech Entertainment. NanoTech Entertainment is now in the process of completing a full inventory of the collection, with the final goal being to make the audio and video available on all of its streaming channels.
“After a long time, we finally found the perfect home for the Sammy Davis Jr. video library,” said Mrozowski. “NanoTech has the capabilities to convert the files, but more importantly I know they share my passion for the collection. They will continue to preserve the legacy of Sammy Davis, Jr. and help to re-establish visibility of these assets after many years.”
“At NanoTech, we believe in the importance of preserving the history of this iconic entertainer,” said Alex “Lx” Rudis, vice president of product development at NanoTech Entertainment. “I have only sorted through one case of materials, but I have already discovered Sammy Davis, Jr.’s personal collection of Frank Sinatra tapes and an Oscar Peterson recording. This collection truly gives you an insight into Mr. Davis’ life and by making this historic collection available on NanoTech’s channels, we are allowing it to live on for future generations.”
In addition to the 2,500 audio and videotapes, the collection also includes two stage cases, one personal audio and video case, reel-to-reel studio master tapes, and an 8mm personal film collection. NanoTech Entertainment is currently exploring the possibility of doing both a live exhibit in addition to an online exhibit.
For more information, contact Kate Connors at 202-449-9804 to talk with NanoTech Entertainment about the collection.
About NanoTech Entertainment
Headquartered in San Jose, CA, NanoTech Entertainment is a technology company that focuses on all aspects of the entertainment industry. With five technology business units, focusing on 3D, Gaming, Media & IPTV, Mobile Apps, and Manufacturing, the company has a unique business model. The company has a diverse portfolio of products and technology. NanoTech Gaming Labs operates as a virtual manufacturer, developing its technology and games, and licensing them to third parties for manufacturing and distribution in order to keep its overhead extremely low and operations efficient in the new global manufacturing economy. NanoTech Media develops proprietary technology which it licenses to publishers for use in their products as well as creating and publishing unique content. NanoTech Communications develops and sells proprietary apps and technology in the Mobile and Consumer space. Clear Memories is the global leader in 3D ice carving and manufacturing technology. NanoTech is redefining the role of developers and manufacturers in the global market. More information about NanoTech Entertainment and its products can be found on the web at www.NanoTechEnt.com.
"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.
The NanoTech Entertainment logo is a trademark of NanoTech Entertainment, Inc. NanoFlix, NanoTales, NanoBooks, Nuvola NP-1, Nuvola NP-C, Nuvola GP-1, Nuvola RF-10 are trademarks of NanoTech Media Corporation. All rights reserved. All other marks are the property of their respective owners. “The Future of Television” is a service mark of NanoTech Entertainment, Inc., All Rights Reserved
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20131206005294/en/
Copyright Business Wire 2013
Source: Business Wire (December 6, 2013 - 8:21 AM EST)
News by QuoteMedia
www.quotemedia.com
NEWS Axiologix, Inc. Annual Revenues To Exceed $14 Million With Completion Of Acquisition Of Leading VoIP Service Provider In Emerging Markets
3:21 PM ET 12/5/13 | PR Newswire
Axiologix, Inc. (www.axiologix.net) (Pinksheets: AXLX), an International Technology and Services Organization focused on delivering 'Cloud' telecom Products and Services globally, today announced that it has recently completed the acquisition of iWorld Services, a market leader in delivering retail and wholesale VoIP services, products, and advanced web applications and software tools targeting high growth emerging markets.
Founded in 2007, iWorld Services is located in the San Francisco Silicon Valley area and provides market specific turnkey hosted solutions for VoIP resellers, distributors, and small medium businesses globally. It is a market leader in Africa, Middle East and is expanding to South America and Asia.
The initial consideration of $6 million consists of $750,000 in cash, $2,750,000 in loan notes payable quarterly after 12 months and $2,500,000 in Preferred shares of Axiologix, Inc. There is a potential for additional cash consideration of up to $4,500,000 based on profitability of iWorld Services over the next three years. Axiologix drew an additional $1.75 million from its revolving line of credit with TCA to provide the cash portion of the transaction, cover transaction costs and provide working capital to fund growth of the business going forward. Full details of the transaction and financing have been filed at: http://www.otcmarkets.com/stock/AXLX/filings
The management team at iWorld is staying with the group post transaction, with Mr. Falchi transitioning from CEO to President of iWorld Services in a continuing role.
Mr. Falchi, President of iWorld Services said, "We are very pleased and excited with this acquisition by Axiologix as it will allow us to underpin our activities in the high growth emerging markets and provide the necessary marketing and technology experience to continue our expansion and to bring additional services and products to our existing 300 distribution and reseller partners going forward. We operate in a very fast moving and ever changing marketplace and being part of the Axiologix group, and their plans for further strategic and complimentary acquisitions, leads us to believe that we have chosen the correct time to sell to the correct partner to move the business forward."
Vincent Browne, Chairman and Chief Executive of Axiologix Inc. and iWorld Services said, "This is clearly a very significant event for Axiologix as we report the successful completion of this strategic and immediately revenue accretive addition to our business. We are impressed with the distribution network that iWorld has created over the years and also the specific technologies and the powerful multi-level network infrastructure they have developed to service the unique characteristics of these markets. We will be bringing additional products and services to these markets throughout the course of next year to improve revenues and gross margins from these valuable markets. It is also significant in that it shows our ability to close transactions using our current funding methods and will therefore make future targeted acquisitions more confident in our ability to close as we move to complete them in 2014."
About Axiologix, Inc.
Axiologix Inc. is an International Technology and Services Organization focused on delivering Cloud-based telecom Products and Services to small and medium sized businesses primarily in the United States and to operators globally. Axiologix is headquartered in Florida, with international operations in Dublin, Ireland. Additional information may be found at www.axiologix.net
This press release contains forward-looking statements. Words such as "expects", ``intends'', ``believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the Securities and Exchange Commission and the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
SOURCE Axiologix, Inc.
http://rt.prnewswire.com/rt.gif?NewsItemId=CG28655&Transmission_Id=201312051521PR_NEWS_USPR___
NEWS:Far Vista Petroleum Corp is in the process of reinstatement
2:46 PM ET 12/5/13 | PR Newswire
Far Vista Petroleum Corp (FVSTA, PinkSheets)
On November 8, 2013, the Company had its trading status suspended until November 22, 2013.
Far Vista announces that it is currently doing all that is necessary to re-establish its status as a company providing "Current Information" on the OTC Pinkmarketplace. Far Vista's corporate/securities attorney is preparing a Form 15c2-11, which we expect will be completed shortly.
The Company has received a notice from the Commercial Bank InterCredit which represents the interested party making an offer to purchase the shares of the Company. It advises that the negotiations have been held back until the Company re-establishes its status. The correspondence from the Bank is posted on the OTC site: http://www.otcmarkets.com/financialReportViewer?symbol=FVSTA&id=114408
About Far Vista Petroleum Corp
Far Vista Petroleum Corp has business objectives of interacting with Russian operators in the oil/gas industry with the goal of building a vertically integrated petroleum company based on opportunities available in the Russian Federation. This will be accomplished through acquisitions of interests to develop crude oil sites with proven reserves by means of equity investment or joint ventures.
Forward-Looking Statements
This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future.
SOURCE Far Vista Petroleum Corp.
http://rt.prnewswire.com/rt.gif?NewsItemId=TO982&Transmission_Id=201312051446PR_NEWS_USPR____
IGNT Board of Directors Approve Move to the OTCQB
RIVERSIDE, Calif., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Ingen Technologies Inc. (OTC:IGNT), (http://ingen-tech.com) the holding company of two subsidiaries; a medical device manufacturing company selling its patented medical products worldwide, and a newly acquired growing telecom business providing services to major telecom companies worldwide, announces today that pursuant to a special meeting held by the Board of Directors on December 1st, 2013, the Board had majority vote to move all of the assets and liabilities, including shareholder equity and all of its note holders to a OTCQB listing.
"We are inviting all of our shareholders and other investors to a scheduled telephone conference session on December 16th, 2013 at 10am pacific standard time. It has been a very good year for Ingen, and members of our Board of Directors, including myself, would like to hold a conference to discuss events from our last Board Meeting," Stated Gary Tilden, Chairman. Mr. Tilden further stated, "Ingen has assets in both of its subsidiaries, and moving to a fully reporting QB company that is DTCC and DWAC eligible will allow greater liquidity to our shareholders, and better funding opportunities to expand our subsidiaries."
The company will provide a full report on its assets and discuss a new dividend program for its shareholders. In order to participate in the telephone conference please email your request to GaryTilden@Ingen-Tech.com and he will provide the call-in instructions for the conference.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
CONTACT: Gary Tilden
951-688-7840
www.ingen-tech.com
info@ingen-tech.com
www.useatmc.com
Ingen ATMC logo
Source: Globe Newswire (December 5, 2013 - 2:21 PM EST)
News by QuoteMedia
www.quotemedia.com
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201
NORTHVALE, N.J., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pilot bioequivalence study in healthy volunteers for ELI-201, the Company's twice daily abuse deterrent oxycodone/naltrexone product.
Elite has met the goal of starting the bio study for ELI-201 in December. A pivotal bioequivalence study for a second abuse deterrent product is scheduled to begin dosing in January 2014, and the pivotal bioequivalence study for ELI-201 is scheduled to begin dosing in March 2014. The bioequivalence studies for these opioid abuse deterrent products are being conducted under the direction of Camargo Pharmaceutical Services.
"The start of the ELI-201 pilot study marks a major milestone for the development of products utilizing our proprietary abuse deterrent technology," said Nasrat Hakim, Elite's President and CEO. "I am extremely pleased with the progress Elite has made with the development of this technology. We have set several initiatives in motion and all of our research and development projects are on or ahead of schedule. We appreciate the guidance and expertise that has been provided by Camargo and look forward to this next phase for the Company."
About Elite's Abuse Deterrent Technology
Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed or dissolved, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
About Camargo Pharmaceutical Services
Camargo is a full-service drug development partner specializing in the 505(b)(2) process — an approach for developing products that offer differentiated benefits. Camargo is capable of managing every facet of the plan throughout the development continuum, from feasibility assessments, formulation and testing the drug product, to conducting preclinical and clinical studies, to final submission.
About Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite's strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products and developing generic versions of controlled release drug products with high barriers to entry. Elite has six commercial products currently being sold, an additional product approved and soon to be launched, eleven approved products pending manufacturing site transfer and two additional products under review pending approval by the FDA. Elite's lead pipeline products include abuse resistant opioids utilizing the Company's patented proprietary technology, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.) and has partnered with Epic Pharma for the manufacturing and distribution of eleven approved products pending manufacturing site, with Hi-Tech Pharmacal to develop an intermediate for a generic product, and a Hong Kong based company to develop a branded product for the United States market and its territories. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.
This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Including those related to the effects, if any, on future results, performance or other expectations that may have some correlation to the subject matter of this press release, readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, its ability to obtain FDA approval of the transfers of the ANDAs or the timing of such approval process, delays, uncertainties, inability to obtain necessary ingredients and other factors not under the control of Elite, which may cause actual results, performance or achievements of Elite to be materially different from the results, performance or other expectations that may be implied by these forward-looking statements. These risks and other factors, including, without limitation, the Company's ability to obtain sufficient funding under the LPC Agreement or from other sources, the timing or results of pending and future clinical trials, regulatory reviews and approvals by the Food and Drug Administration and other regulatory authorities, intellectual property protections and defenses, and the Company's ability to operate as a going concern, are discussed in Elite's filings with the Securities and Exchange Commission, including its reports on forms 10-K, 10-Q and 8-K. Elite undertakes no obligation to update any forward-looking statements.
CONTACT: Elite Pharmaceuticals, Inc.
Dianne Will, Investor Relations, 518-398-6222
Dianne@elitepharma.com
Elite Pharmaceuticals, Inc Logo
Source: Globe Newswire (December 5, 2013 - 12:50 PM EST)
News by QuoteMedia
www.quotemedia.com
AFYG - Added a few today also Holding a decent amount , nothing crazy. Going to wait until an upward trend ( News ) to add more. GL
Fresh Healthy Vending's Shares Could Double From Current Levels
2:15 PM ET 12/3/13 | Marketwire
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, notes that in an article published today on Fresh Healthy Vending International, Inc. (OTCQB: VEND), a leading healthy vending franchisor, the continued achievement of key milestone events could return the stock to the $4.00 level, which is essentially a doubling of its present share price.
California-based Fresh Healthy Vending is a leading healthy vending franchisor that pioneered the concept of vending machines stocked with tried-and-tested fresh, healthy snack options and capitalizes on a growing market of health conscious consumers. The company has appointed more than 205 franchisees throughout the United States, Canada, Puerto Rico and the Bahamas. Fresh Healthy Vending has more than 2,300 machines installed in schools, universities, hospitals, community centers, military bases, airports, fitness facilities, YMCAs, libraries and many other types of locations.
In an effort to fight obesity and diabetes, schools and colleges around the country are replacing the traditional vending machines that offer high-sugar, high calorie, and high fat foods with those that offer healthy foods. In fact, many school systems throughout the U.S. are mandated to replace the existing installed base of products with healthier options. The problem is that many of the vending machines in the $42 billion industry are ill-equipped to truly offer healthier alternatives. As a result, the current machines must be taken out and replaced by better options.
Enter VEND.
The company offers three different machines: The Healthy Vending Combo snack and drink machine, Healthy Vending Cafe that brews gourmet hot beverages in less than 40 seconds and the brand new Healthy Vending Touch -- the only 46" 3D interactive touch screen vending machine.
The company is hitting on all cylinders as outlined by a very positive news release earlier this week. Fresh Healthy Vending announced that November sales were the company's highest monthly sales ever, highlighted by the addition of 57 new location contracts and the first sale of the Healthy Vending Touch machine. Separately, the company also added a number of new franchisees during the month.
The stock reached a peak of $4.05 and sold off following an article on Seeking Alpha which offered a differing opinion on the company's prospects. The subsequent sell-off presents a great opportunity for investors to step in at an attractive price that happens to be on the heels of the solid November news released on Monday.
With the healthy replacement vending machine trend at its back, we believe that the contract sizes for the company will increase not just in number but in size as well. In our view, as additional contract, franchisee, and sales milestones are reached, VEND's stock could return to or exceed its year-high.
This press release contains excerpts of our most recently published article on Fresh Healthy Vending International Inc. Goldman Small Cap Research was not compensated for this article. To view the disclosures and disclaimers, or to download the article in its entirety, please visit www.goldmanresearch.com.
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and micro cap stock research reports, articles, daily stock market blogs, and popular investment newsletters. Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.
A Goldman Small Cap Research report, update, newsletter, or article is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com.
About Fresh Healthy Vending International, Inc. (OTCQB: VEND): Fresh Healthy Vending, based in San Diego, California, is a leading healthy vending franchisor. Fresh Healthy Vending pioneered the concept of vending machines stocked with tried-and-tested fresh, healthy snack options and capitalizes on a growing market of health conscious consumers. The company has appointed more than 205 franchisees throughout the United States, Canada, Puerto Rico and the Bahamas and is looking to partner with like-minded entrepreneurs who share its vision.
For more information, visit the Company's website http://www.FreshVending.com.
Goldman Small Cap Research
Rob Goldman
Analyst
410-609-7100
rob@goldmanresearch.com
SOURCE: Goldman Small Cap Research, Inc.
Terra Tech Subsidiary Edible Garden Signs Distribution Deal with 30-Acre Midwest Sustainable Hydroponic Farm
11:57 AM ET 12/3/13 | GlobeNewswire
Terra Tech Corp (TRTC) subsidiary Edible Garden, a hydroponic herb and produce cultivator, signed a distribution deal with Heartland Growers out of Indianapolis, Indiana. Under the terms of the deal Heartland will cultivate the full line of Edible Garden produce to be sold throughout the Midwest market. Terra Tech will manage the marketing and sales, while Heartland will be responsible for the cultivation, packaging, and shipping of the product for retail sale.
"With over thirty acres of greenhouse space, Heartland operates a significant footprint for us to launch our product throughout the Midwest," says Derek Peterson, CEO of Terra Tech Corp. "They are one of the largest flower cultivators in the US and their ability to farm as well as manage the logistics associated with servicing retail is unsurpassed in our opinion. This is an important market for us to penetrate and Heartland gives us the capacity to scale quickly without raising additional capital to construct a new facility."
Edible Garden selected Heartland due to their eco-conscious approach to cultivation. Heartland recycles water, utilizes no harmful pesticides, and repurposes methane gas collected from a local landfill to heat their facility. They cultivate using energy and labor efficient Dutch-style equipment to maximize output while minimizing costs. Heartland Growers has already begun seeding for hydroponic lettuce and the company is actively meeting with retail buyers to carry their line of living produce.
"Consumers are beginning to demand locally-grown produce out of the concern for the environment as well as the safety of the food they feed their families. Shopping locally also gives consumers a way to prioritize and support businesses in their local community," explains Austin Kirtley VP of Sales and Marketing. "We are excited about our partnership with Edible Garden and believe strongly in their model of creating a national brand of sustainably farmed produce cultivated by a network of local farmers."
Outside of their flagship hydroponic farm in the Northeast, the company intends on partnering with existing operators throughout the country to expand the Edible Garden brand. The model is designed to minimize dilution and the need for capital while allowing for scalability to expand their footprint as quickly as possible.
"Our intention is to find existing farms with excess capacity and show them how they can cultivate a product that has year-round demand, reducing the seasonality of their core business, said Ken Vande Vrede COO of Terra Tech. "Through partnering we can maintain quality and packaging standards nationwide while avoiding shipping our products long distances in an effort to offer consumers a brand they know and trust from a local farm they feel good about supporting."
About Terra Tech
Terra Tech Corp. (TRTC) through its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. The company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Our complete product line is available at specialty retailers throughout the United States, and via our website. Through its wholly-owned subsidiary Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Food Emporium and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, and Pennsylvania.
For more information on Heartland Growers visit: www.heartlandgrowers.com
For more information about Terra Tech Corp visit: www.terratechcorp.com
Visit us on Facebook @ http://www.facebook.com/terratechcorp
Follow us on Twitter @terratechcorp
For more information about Edible Garden visit: http://www.ediblegarden.com
Visit Edible Garden on Facebook @ https://www.facebook.com/ediblefarms
Cautionary Language Concerning Forward-Looking Statements
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Terra Tech Corp.'s filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to Terra Tech Corp.'s (i) product demand, market and customer acceptance of its equipment and other goods, (ii) ability to obtain financing to expand its operations, (iii) ability to attract qualified sales representatives, (iv) competition, pricing and development difficulties, (v) ability to integrate GrowOp Technology Ltd. into its operations as a reporting issuer with the Securities and Exchange Commission, and (vi) general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Terra Tech Corp.'s website does not constitute a part of this release.
CONTACT: Bill Clayton
Independence Financial Ltd.
Toll-Free: (888) 603-2896
Email: info@terratechcorp.com
http://media.globenewswire.com/cache/26002/small/19634.jpg
http://www.globenewswire.com/newsroom/ti?nf=MTMjMTAwNjAyMjIjMjYwMDI=
Happy Anniversary ATS !!! I'm a little late to the party, as usual, but the board has come a long way in a year. Excellent job AT , mods , and all the poster's!!! Ill stop by more often , I've been trading precious metals last couple of months. Hardly any penny's. Glad to see you guy's/gal's are hitting the Nazzy's.. Good idea.
This is for AT. Saw this plate a few month's ago in NYC :
Either this dude LOVE RATS or he is a LOVER of ATS hahah